Stanford researchers found that a single dose of ibogaine may dramatically reduce PTSD and TBI symptoms in veterans—offering ...

Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced a strategic follow-on investment of ...

Proponents of the controversial drug ibogaine say it resets the brain to its pre-addictive state and takes away symptoms of detox, withdrawal and cravings. However, it also has serious and ...

Ibogaine, a naturally occurring psychoactive substance derived from the Tabernanthe iboga plant, has shown promise in early-stage research for its unique ability to interrupt SUDs, offering a ...

Derived from the root bark of the Tabernanthe iboga shrub, Iboga is a powerful plant medicine traditionally used by the Bwiti people of Central Africa—specifically Gabon, Cameroon, and the ...

Psyence Biomedical (NASDAQ: PBM) invested an additional $500,000 in PsyLabs, deepening its relationship with the psychedelic ingredients producer while securing exclusive access to ...